Home » Authors » Don Long

Don Long

Articles

ARTICLES

Financings roundup: One-third or more of Frazier’s $475M fund to target devices

June 1, 2005

Light in dental office leads to Mediscience's optical imaging

May 26, 2005

J&J: Reports of flawed ICDs won’t stop its buy of Guidant

May 25, 2005

Boston Sci-Aspect deal brings devices to ‘personalized med’

May 24, 2005

‘Leak’ called attempt to block Cyberonics VNS for depression

May 20, 2005

Regulatory saga longstanding for Cyberonics’ VNS therapy

May 20, 2005

Trials back promise of Halo360 from Barrx for Barrett’s therapy

May 19, 2005

Light in dental office leads to Mediscience’s optical imaging

May 17, 2005

New CMS ‘3-pronged’ criteria will guide new mobility coding

May 9, 2005

Commentary: Knowledge about devices and makers not always a positive

May 9, 2005

View All Articles by Don Long

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...